Topics

Assembly Bio Taps Gilead’s Thomas Russo as Chief Financial Officer

18:18 EDT 28 Oct 2019 | Xconomy

Thomas Russo has left Gilead Sciences (NASDAQ: GILD) to become chief financial officer of Assembly Biosciences (NASDAQ: ASMB). Russo held a number of positions during his seven years at Gilead, and was most recently vice president and head of commercial finance. His experience also includes posts at Robert W. Baird & Co. and Merck (NYSE: […]

Original Article: Assembly Bio Taps Gilead’s Thomas Russo as Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Assembly Bio Taps Gilead’s Thomas Russo as Chief Financial Officer"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...